![Ajan Reginald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 31/12/2025
Ajan Trevor Reginald is the founder of Cell Therapy Ltd., established in 2009, serving as Chief Executive Officer & Executive Director.
Current jobs include Chairman at Oncogeni Ltd., Director at Desktop Genetics Ltd., and Managing Director, Secretary & Executive Director at Cardiogeni Plc since 2019.
Former jobs include Director-Business Development at Roche Pharmaceuticals, Inc., Chief Executive Director & Executive Director at Coiled Therapeutics Plc from 2022 to 2025, Global Head-Emerging Technologies at Roche Group, and Chief Operating & Technology Officer at Novacyt SAS. Education history includes graduate studies at the University of Oxford, undergraduate studies at the University of London, and an MBA from Kellogg School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Celixir Plc
 Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases 24,94 % | 21/04/2026 | 22.223.711 ( 24,94 % ) | 2 M $ | 31/12/2025 |
COILED THERAPEUTICS PLC 0,09 % | 24/11/2025 | 380.508 ( 0,09 % ) | 49 926 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Cell Therapy Ltd.
 Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Fundador | 01/01/2009 |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Director Ejecutivo | 28/12/2016 |
Desktop Genetics Ltd.
 Desktop Genetics Ltd. Packaged SoftwareTechnology Services Develops software tools to enable literal desktop genetics | Director/Miembro de la Junta | - |
Oncogeni Ltd.
 Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ROQT THER | Director Ejecutivo | 17/03/2025 |
| NOVACYT | Director de Operaciones | - |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Corporate Officer/Principal | - |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacyt SAS
 Novacyt SAS Medical SpecialtiesHealth Technology Designs, develops and markets molecular real-time PCR testing devices and reagents in the areas of infectious diseases | Health Technology |
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Desktop Genetics Ltd.
Desktop Genetics Ltd. Packaged SoftwareTechnology Services Develops software tools to enable literal desktop genetics | Technology Services |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Health Technology |
Roquefort Therapeutics Plc
 Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
Oncogeni Ltd.
Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
